ORX:STO
Orexo AB
1,37 SEK
arrow_downward
-1,58%(-0,022) 1D
6 қар., 17:29:49 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Central Oregon Daily
·
12 минут бұрын
Nasdaq rebounds but posts fourth straight weekly decline
TradingView
·
1 сағат бұрын
QQQ Vs. TQQQ: 3X Nasdaq ETFs Compounding Trap Is Costing Investors Big
Benzinga
·
14 минут бұрын
Nasdaq 100 Has Worst Day Since 2020, Jobs Beat Keeps Fed Hike Alive: This Week on Wall Street
Seeking Alpha
·
3 минут бұрын
U.S. indexes will hit new highs within three months, says SA analyst
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com